Background/aims This study evaluated the performance of artificial intelligence (AI) algorithms in predicting best-corrected ...

ARTEMIS Phase 3 trial enrollment exceeding expectations; driven by strong retina specialist and patient enthusiasm for a potential One And DoneTM ...

We are thrilled to report excellent progress in the ARTEMIS Phase 3 trial, with enrollment driven by robust interest from retina specialists and ...

Target Audience The intended audience for the activity is US-based ophthalmologists, retina specialists, and optometrists involved in the management of retinal diseases.

ANI Pharmaceuticals' Q2 2025 earnings report highlights record revenues, strong Cortrophin Gel demand, and raised guidance.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Detecting retinal diseases is crucial for preventing vision loss, but it comes with challenges, such as data imbalance and accurately classifying rare conditions. This study introduces a new ensemble ...

Optomed Lumo launches a versatile handheld fundus camera, enhancing retinal imaging accessibility in diverse healthcare ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early or intermediate age-related macular degeneration (AMD) eyes to new ...

WASHINGTON (AP) — Canada's announcement it will recognize a Palestinian state “will make it very hard” for the United States to reach a trade agreement with its northern neighbor, President ...

Australia, UK leaders discuss Gaza crisis amid Palestinian state recognition plans By Reuters July 30, 20255:06 PM PDTUpdated July 30, 2025 ...